Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.

Ribaudo HJ, Smith KY, Robbins GK, Flexner C, Haubrich R, Chen Y, Fischl MA, Schackman BR, Riddler SA, Gulick RM.

Clin Infect Dis. 2013 Dec;57(11):1607-17. doi: 10.1093/cid/cit595. Epub 2013 Sep 17.

2.

Confidentiality of the medical records of HIV-positive patients in the United Kingdom - a medicolegal and ethical perspective.

Williams M.

Risk Manag Healthc Policy. 2011;4:15-26. doi: 10.2147/RMHP.S8997. Epub 2011 Jan 26.

3.

Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents.

Hartman TL, Yang L, Buckheit RW Jr.

Antiviral Res. 2011 Dec;92(3):505-8. doi: 10.1016/j.antiviral.2011.10.013. Epub 2011 Oct 19.

4.

Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, Cameron PU, Petoumenos K, Lewin SR.

PLoS One. 2011;6(6):e20713. doi: 10.1371/journal.pone.0020713. Epub 2011 Jun 2.

5.

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.

Simpson KN, Dietz B, Baran RW, Garren KW, Riddler SA, Bhor M, Haubrich RH.

Cost Eff Resour Alloc. 2011 May 8;9:5. doi: 10.1186/1478-7547-9-5.

6.

Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV.

Chu J, Sloan CE, Freedberg KA, Yazdanpanah Y, Losina E.

AIDS Res Ther. 2011 Mar 10;8:14. doi: 10.1186/1742-6405-8-14.

7.

Indirect comparisons: a review of reporting and methodological quality.

Donegan S, Williamson P, Gamble C, Tudur-Smith C.

PLoS One. 2010 Nov 10;5(11):e11054. doi: 10.1371/journal.pone.0011054. Review.

8.

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

Dieterich DT.

J Int AIDS Soc. 2006 Jan 19;8(1):16. doi: 10.1186/1758-2652-8-1-16. No abstract available.

9.

Clinically informative measures of the effect of drugs or other interventions.

Salmi LR, Suissa S, ChĂȘne G, Salamon R.

Br J Clin Pharmacol. 2008 Jun;65(6):935-41. doi: 10.1111/j.1365-2125.2008.03146.x. Epub 2008 Mar 13.

10.

Disease management--constructing optimal NRTI-based combinations: past, present, and future.

Dieterich DT.

MedGenMed. 2006 Jan 19;8(1):16. Review. No abstract available.

11.

Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.

Martinez V, Caumes E, Gambotti L, Ittah H, Morini JP, Deleuze J, Gorin I, Katlama C, Bricaire F, Dupin N.

Br J Cancer. 2006 Apr 10;94(7):1000-6.

12.

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Caldwell DM, Ades AE, Higgins JP.

BMJ. 2005 Oct 15;331(7521):897-900. Review. No abstract available.

13.

Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs.

Lundgren JD, Phillips AN.

BMJ. 2004 Jan 31;328(7434):253. No abstract available.

14.

Access to antiretroviral treatment in Africa.

Loewenson R, McCoy D.

BMJ. 2004 Jan 31;328(7434):241-2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk